Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Case study of a neuroendocrine tumor of uncertain origin: single-cell transcriptomics unravels potential primary source

ABSTRACT: In this study, we present a clinical case of a patient with a retroperitoneal non-functional non-organ-confined neuroendocrine tumor, as determined by routine testing. The histogenesis of the tumor was assessed based on bulk and single-cell RNA sequencing (bulk RNA-seq and scRNA-seq) data, as standard diagnostic procedures proved ineffective. The use of publicly accessible bulk and single-cell RNA-seq data from pancreatic and small intestinal NETs allowed for the development and validation of gene signatures tailored to each specific localization of origin. Additionally, it enabled the prediction of the primary origin of the previously described NET, indicating that ectopic pancreatic tissue is the most probable source.

ORGANISM(S): Homo sapiens

PROVIDER: GSE282219 | GEO | 2025/01/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Case study of a neuroendocrine tumor of uncertain origin: single-cell transcriptomics unravels potential primary source

Project description:Case study of a neuroendocrine tumor of uncertain origin: single-cell transcriptomics unravels potential primary source

| PRJNA1187602 | ENA

Gene expression of pancreatic tumors

Project description:Solid-pseudopapillary neoplasm of pancreas(SPN), ductal adenocarcinoma(PCA), neuroendocrine tumor(NET) and non-neoplastic pancreas. To investigate the specific gene expression of SPN compared to other types of pancreatic tumor, we analyzed large-scale gene expressioin analysis to identify the molecular signature that may affect SPN tumorigenesis. Differentially expressed genes were analyzed on SPNs, PCAs, NETs and Non-neoplastic tissues. Solid-pseudopapillary neoplasm (SPN) is an uncommon pancreatic tumor with distinct clinicopathologic features. SPNs are characterized by mutations in exon 3 of CTNNB1. However, little is known about the gene and microRNA expression profiles of SPNs. Thus, we sought to characterize SPN-specific gene expression and identify the signaling pathways activated in these tumors. The mRNA expression profile of 14 SPNs, 6 pancreatic adenocarcinomas (PCAs), 6 pancreatic neuroendocrine tumors (NETs), and five non-neoplastic pancreatic tissues were analyzed.

2013-12-31 | E-GEOD-43795 | biostudies-arrayexpress

Gene expression profiling of mouse pancreatic tumors derived from acinar or ductal cells

Project description:Acinar and ductal cells are the major epithelial cell types in the exocrine pancreas, but which of these serves as the cell-of-origin in human PDAC has been debated. Our mouse models have demonstrated that oncogenic Kras expression and Trp53 loss in pancreatic acinar or ductal cells can lead to pancreatic cancer. Here, we performed gene expression profiling of bulk acinar cell-derived and ductal cell-derived mouse pancreatic tumors to identify the transcriptomic profiles.

2021-01-05 | GSE164180 | GEO

The Impact of PAD4-dependent Neutrophil Extracellular Trap formation on the Early Development of Intestinal Fibrosis in Crohn’s Disease

Project description:To explore the potential profibrotic effect of neutrophil extacellular traps (NETs), we investigated the transcriptional modification that NET stimulation determines in the intestine of patients with Crohn's disease(CD). To this end, primary intestinal fibroblasts derived from the ileum of patients with CD were either coltured with NETs for 24 hours or left untreated. Bulk RNA sequencing (RNA-seq) was performed to evaluate the differentially expressed genes and determine the possible profibrogenic signature of this interaction.

2024-08-14 | GSE236655 | GEO

microRNA expression of pancreatic tumors

Project description:Solid-pseudopapillary neoplasm of pancreas (SPN), ductal adenocarcinoma (PCA), neuroendocrine tumor (NET) and non-neoplastic pancreas. comparison with gene expression of tumors and non-tumors To investigate the specific microRNA expression of SPN compared to other types of pancreatic tumor, we analyzed large-scale microRNA expressioin analysis to identify the molecular signature that may affect SPN tumorigenesis with mRNA expression profiles. Differentially expressed microRNAs were analyzed on SPNs, PCAs, NETs and Non-neoplastic tissues.

2013-12-31 | E-GEOD-43796 | biostudies-arrayexpress

Foxl2 functions throughout mouse ovary development

Project description:This SuperSeries is composed of the following subset Series: GSE12905: Foxl2 functions in sex determination and histogenesis throughout mouse ovary development, analyzed by Affymetrix arrays GSE12942: Foxl2 functions in sex determination and histogenesis throughout mouse ovary development, analyzed by Agilent arrays Refer to individual Series

2010-05-17 | E-GEOD-12989 | biostudies-arrayexpress

Candidatus Protochlamydia amoebophila UWE25

Project description:Probable pneumonia agent

| PRJNA10700 | ENA

POG_patient_24465 - samples

Project description:Genome and transcriptome sequence data from an adnexal tumor probable of Wolffian origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

| EGAD00001002600 | EGA

Gene expression profiling of neuroendocrine primary tumors: effect of Octreotide treatment

Project description:Gene expression profiles of primary neuroendocrine tumors treated or not with 1µM Octreotide.We investigated 5 human neuroendocrine cell lines, CNDT2.5 and KRJ1, established from ileum NETs, QGP1 by a pancreatic NET, NCI H720 and NCI H727 from bronchopulmonary NETs. CNDT2.5 cell wereconstantly treated with 1µM octreotide for 10 and 16 months. We isolated total RNA (Ambion, PARIS Kit) from 5 WT cell lines and CNDT2.5 treated with octreotide (Santostatin, Novartis). Total RNA was hybridized onto the Affymetrix Human Gene 1.0 ST Array by Affymetrix Uppsala Platform, UU. SE (Uppsala, Sweden). We first wanted to verify whether the different cell lines may become reliable models to study neuroendocrine signaling pathways. The main objective of this project aimed at understanding the mechanisms by which octreotide (Sandostatin, Novartis) alter cellular growth and differentiation of CNDT2.5 cells. We therefore focused on intermediate (10 months) and long stimulation (16 months) events triggered by sandostatin, which lead variation of CNDT.2.5 cells gene expression to identify potential pivotal genes involved in the development of drug resistance in neuroendocrine cells.

2013-01-08 | E-MTAB-388 | biostudies-arrayexpress

Gene expression of pancreatic tumors

2013-12-31 | GSE43795 | GEO